53
Participants
Start Date
May 4, 2018
Primary Completion Date
November 23, 2021
Study Completion Date
November 23, 2021
AMG 334 Dose 1
"Subjects weighing less than weight threshold at Day 1 will be randomized to either Dose 1 or Dose 3.~Subjects weighing weight threshold or more at Day 1 will be randomized to either Dose 1 or Dose 2"
AMG 334 Dose 2
Subjects weighing weight threshold or more at Day 1 will be randomized to either Dose 1 or Dose 2.
AMG 334 Dose 3
Subjects weighing less than weight threshold at Day 1 will be randomized to either Dose 1 or Dose 3.
State University of New York Upstate Medical University, Syracuse
Dent Neurosciences Research Center, Amherst
PANDA Neurology and Atlanta Headache Specialists, Atlanta
Premiere Research Institute, West Palm Beach
Synergy Health, Bradenton
Nationwide Childrens Hospital, Columbus
Cincinnati Childrens Hospital Medical Center, Cincinnati
Riley Hosptial, Indianapolis
Clinical Research Institute Inc, Plymouth
Childrens Mercy Hospital, Kansas City
Meridian Clinical Research, Hastings
Arkansas Childrens Hospital, Little Rock
CarePoint, Englewood
New England Institute for Clinical Research, Stamford
Lead Sponsor
Amgen
INDUSTRY